Inogen adds executive VP; co-founder Myers to step down
Inogen, a Goleta-based medical technology company that makes portable oxygen concentrators, announced April 7 that it has hired Georg Parr as executive vice president and chief commercial officer. Byron Myers, a member of Inogen’s founding team and the current executive vice president for marketing, will step down on June 4, as will Arron Retterer, the Read More →
Ventura County to enter orange tier; Santa Barbara and SLO lag behind
Ventura County will be the first in the tri-county region to reach the orange tier of California’s COVID-19 reopening system on April 7, while both Santa Barbara and San Luis Obispo counties have failed to progress past the more restrictive red tier. Orange is the second least restrictive tier and means the spread of COVID Read More →
Bank of America buys Santa Barbara health care payment company
Axia Technologies, a Santa Barbara-based health care payment and technology company, has been acquired by Bank of America. The terms of the acquisition were not immediately announced, but in an April 2 news release announcing the deal, Bank of America said the move is part of a lager strategy to bring additional merchant services onto Read More →
Inogen’s new CEO looks to the future
As life begins to regain a bit of the normalcy that existed before the COVID-19 pandemic, Goleta-based Inogen is ready to not only get back to its roots, but also lay the foundation for a new direction for the company. Inogen, a medical device company specializing in portable oxygen concentrators, hired a new CEO on Read More →
Region’s clinics get almost $60M in federal COVID funds
Several Central Coast health centers are getting nearly $60 million in total federal funds to help expand access to COVID-19 vaccines, testing and treatment because of the American Rescue Plan. Of the six centers, Community Health Centers of the Central Coast, which is based in Nipomo, received the most money, with $18.7 million. Three organizations Read More →
Revenues and losses both grew at Cure in 2020
Cure Pharmaceutical, an Oxnard company with a CBD products subsidiary, reported steep revenue growth but rising net losses in the fourth quarter and full year of 2020. In an annual statement released April 1, Cure reported revenue of $2.1 million in the final quarter of 2020, up 229% from the same quarter a year before. Read More →
Amgen announces $721M acquisition
Amgen reported its second major acquisition of the month, as the Thousand Oaks-based firm announced March 30 that it will acquire Rodeo Therapeutics Corporation, a privately held biotech company based in Seattle. The deal is worth more than $700 million, $55 million of which will be paid upfront, with up to $666 million more in Read More →
